The dosage of Lantus is individualized and depends on several factors, such as the type of diabetes being treated, your body weight, blood sugar goals, and response to treatment. Lantus is given as a ...
BRIDGEWATER, N.J., Feb. 26 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) approved Apidra(R) SoloSTAR(R ...
Lantus, a long-acting insulin glargine, offers stable 24-hour blood sugar control for people with type 1 and type 2 diabetes. It is often introduced when other treatments are insufficient, and can be ...